PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD)

References

• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993; 72:971-83; PMID:8458085; http://dx.doi.org/10.1016/0092-8674(93)90585-E
   PubMed Web of Science ®Google Scholar
• Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 2014; 10:204-16; PMID:24614516; http://dx.doi.org/10.1038/nrneurol.2014.24
   PubMed Web of Science ®Google Scholar
• Ross CA, Tabrizi SJ. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011; 10:83-98; PMID:21163446; http://dx.doi.org/10.1016/S1474-4422(10)70245-3
   PubMed Web of Science ®Google Scholar
• Walker FO. Huntington's disease. Lancet 2007; 369:218-28; PMID:17240289; http://dx.doi.org/10.1016/S0140-6736(07)60111-1
   PubMed Web of Science ®Google Scholar
• Boutell JM, Thomas P, Neal JW, Weston VJ, Duce J, Harper PS, Jones AL. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum Mol Genet 1999; 8:1647-55; PMID:10441327; http://dx.doi.org/10.1093/hmg/8.9.1647
   PubMed Web of Science ®Google Scholar
• Harjes P, Wanker EE. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 2003; 28:425-33; PMID:12932731; http://dx.doi.org/10.1016/S0968-0004(03)00168-3
   PubMed Web of Science ®Google Scholar
• Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 2002; 22:1277-87; PMID:11839795; http://dx.doi.org/10.1128/MCB.22.5.1277-1287.2002
   PubMed Web of Science ®Google Scholar
• Li SH, Gutekunst CA, Hersch SM, Li XJ. Interaction of huntingtin-associated protein with dynactin P150Glued. J Neurosci 1998; 18:1261-9; PMID:9454836
   PubMed Web of Science ®Google Scholar
• Li SH, Li XJ. Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet 2004; 20:146-54; PMID:15036808; http://dx.doi.org/10.1016/j.tig.2004.01.008
   PubMed Web of Science ®Google Scholar
• Lim J, Crespo-Barreto J, Jafar-Nejad P, Bowman AB, Richman R, Hill DE, Orr HT, Zoghbi HY. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 2008; 452:713-8; PMID:18337722; http://dx.doi.org/10.1038/nature06731
   PubMed Web of Science ®Google Scholar
• Nucifora FC, Jr., Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 2001; 291:2423-8; PMID:11264541; http://dx.doi.org/10.1126/science.1056784
   PubMed Web of Science ®Google Scholar
• Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 2000; 97:6763-8; PMID:10823891; http://dx.doi.org/10.1073/pnas.100110097
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Sixt KM, Barrow R, Snyder SH. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 2009; 324:1327-30; PMID:19498170; http://dx.doi.org/10.1126/science.1172871
   PubMed Web of Science ®Google Scholar
• Zoghbi HY, Orr HT. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J Biol Chem 2009; 284:7425-9; PMID:18957430; http://dx.doi.org/10.1074/jbc.R800041200
   PubMed Web of Science ®Google Scholar
• Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 2006; 15:965-77; PMID:16467349; http://dx.doi.org/10.1093/hmg/ddl013
   PubMed Web of Science ®Google Scholar
• Lee J, Hwang YJ, Kim KY, Kowall NW, Ryu H. Epigenetic mechanisms of neurodegeneration in Huntington's disease. Neurotherapeutics 2013; 10:664-76; PMID:24006238; http://dx.doi.org/10.1007/s13311-013-0206-5
   PubMed Web of Science ®Google Scholar
• Ma B, Culver BP, Baj G, Tongiorgi E, Chao MV, Tanese N. Localization of BDNF mRNA with the Huntington's disease protein in rat brain. Mol Neurodegener 2010; 5:22; PMID:20507609; http://dx.doi.org/10.1186/1750-1326-5-22
   PubMed Web of Science ®Google Scholar
• Ratovitski T, Chighladze E, Arbez N, Boronina T, Herbrich S, Cole RN, Ross CA. Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle 2012; 11:2006-21; PMID:22580459; http://dx.doi.org/10.4161/cc.20423
   PubMed Web of Science ®Google Scholar
• Runne H, Regulier E, Kuhn A, Zala D, Gokce O, Perrin V, Sick B, Aebischer P, Deglon N, Luthi-Carter R. Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry. J Neurosci 2008; 28:9723-31; PMID:18815258; http://dx.doi.org/10.1523/JNEUROSCI.3044-08.2008
   PubMed Web of Science ®Google Scholar
• Savas JN, Ma B, Deinhardt K, Culver BP, Restituito S, Wu L, Belasco JG, Chao MV, Tanese N. A role for huntington disease protein in dendritic RNA granules. J Biol Chem 2010; 285:13142-53; PMID:20185826; http://dx.doi.org/10.1074/jbc.M110.114561
   PubMed Web of Science ®Google Scholar
• Savas JN, Makusky A, Ottosen S, Baillat D, Then F, Krainc D, Shiekhattar R, Markey SP, Tanese N. Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies. Proc Natl Acad Sci U S A 2008; 105:10820-5; PMID:18669659; http://dx.doi.org/10.1073/pnas.0800658105
   PubMed Web of Science ®Google Scholar
• Sipione S, Rigamonti D, Valenza M, Zuccato C, Conti L, Pritchard J, Kooperberg C, Olson JM, Cattaneo E. Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum Mol Genet 2002; 11:1953-65; PMID:12165557; http://dx.doi.org/10.1093/hmg/11.17.1953
   PubMed Web of Science ®Google Scholar
• Tauber E, Miller-Fleming L, Mason RP, Kwan W, Clapp J, Butler NJ, Outeiro TF, Muchowski PJ, Giorgini F. Functional gene expression profiling in yeast implicates translational dysfunction in mutant huntingtin toxicity. J Biol Chem 2010; 286:410-9; PMID:21044956; http://dx.doi.org/10.1074/jbc.M110.101527
   PubMed Web of Science ®Google Scholar
• Valor LM. Transcription, Epigenetics and Ameliorative Strategies in Huntington's Disease: a Genome-Wide Perspective. Mol Neurobiol 2015; 51:406-23; PMID:24788684
   PubMed Web of Science ®Google Scholar
• Wyttenbach A, Swartz J, Kita H, Thykjaer T, Carmichael J, Bradley J, Brown R, Maxwell M, Schapira A, Orntoft TF, Kato K, Rubinsztein DC. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum Mol Genet 2001; 10:1829-45; PMID:11532992; http://dx.doi.org/10.1093/hmg/10.17.1829
   PubMed Web of Science ®Google Scholar
• Zucker B, Luthi-Carter R, Kama JA, Dunah AW, Stern EA, Fox JH, Standaert DG, Young AB, Augood SJ. Transcriptional dysregulation in striatal projection-and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1. Hum Mol Genet 2005; 14:179-89; PMID:15548548; http://dx.doi.org/10.1093/hmg/ddi014
   PubMed Web of Science ®Google Scholar
• Blackwell E, Ceman S. Arginine methylation of RNA-binding proteins regulates cell function and differentiation. Mol Reprod Dev 2012; 79:163-75; PMID:22345066; http://dx.doi.org/10.1002/mrd.22024
   PubMed Web of Science ®Google Scholar
• Wolf SS. The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans. Cell Mol Life Sci 2009; 66:2109-21; PMID:19300908; http://dx.doi.org/10.1007/s00018-009-0010-x
   PubMed Web of Science ®Google Scholar
• Ancelin K, Lange UC, Hajkova P, Schneider R, Bannister AJ, Kouzarides T, Surani MA. Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat Cell Biol 2006; 8:623-30; PMID:16699504; http://dx.doi.org/10.1038/ncb1413
   PubMed Web of Science ®Google Scholar
• Branscombe TL, Frankel A, Lee JH, Cook JR, Yang Z, Pestka S, Clarke S. PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem 2001; 276:32971-6; PMID:11413150; http://dx.doi.org/10.1074/jbc.M105412200
   PubMed Web of Science ®Google Scholar
• Le Guezennec X, Vermeulen M, Brinkman AB, Hoeijmakers WA, Cohen A, Lasonder E, Stunnenberg HG. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol 2006; 26:843-51; PMID:16428440; http://dx.doi.org/10.1128/MCB.26.3.843-851.2006
   PubMed Web of Science ®Google Scholar
• Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 2004; 24:9630-45; PMID:15485929; http://dx.doi.org/10.1128/MCB.24.21.9630-9645.2004
   PubMed Web of Science ®Google Scholar
• Pal S, Yun R, Datta A, Lacomis L, Erdjument-Bromage H, Kumar J, Tempst P, Sif S. mSin3A/histone deacetylase 2-and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad. Mol Cell Biol 2003; 23:7475-87; PMID:14559996; http://dx.doi.org/10.1128/MCB.23.21.7475-7487.2003
   PubMed Web of Science ®Google Scholar
• Friesen WJ, Paushkin S, Wyce A, Massenet S, Pesiridis GS, Van Duyne G, Rappsilber J, Mann M, Dreyfuss G. The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins. Mol Cell Biol 2001; 21:8289-300; PMID:11713266; http://dx.doi.org/10.1128/MCB.21.24.8289-8300.2001
   PubMed Web of Science ®Google Scholar
• Meister G, Eggert C, Buhler D, Brahms H, Kambach C, Fischer U. Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr Biol 2001; 11:1990-4; PMID:11747828; http://dx.doi.org/10.1016/S0960-9822(01)00592-9
   PubMed Web of Science ®Google Scholar
• Jansson M, Durant ST, Cho EC, Sheahan S, Edelmann M, Kessler B, La Thangue NB. Arginine methylation regulates the p53 response. Nat Cell Biol 2008; 10:1431-9; PMID:19011621; http://dx.doi.org/10.1038/ncb1802
   PubMed Web of Science ®Google Scholar
• Boisvert FM, Cote J, Boulanger MC, Cleroux P, Bachand F, Autexier C, Richard S. Symmetrical dimethylarginine methylation is required for the localization of SMN in Cajal bodies and pre-mRNA splicing. J Cell Biol 2002; 159:957-69; PMID:12486110; http://dx.doi.org/10.1083/jcb.200207028
   PubMed Web of Science ®Google Scholar
• Hebert MD, Shpargel KB, Ospina JK, Tucker KE, Matera AG. Coilin methylation regulates nuclear body formation. Dev Cell 2002; 3:329-37; PMID:12361597; http://dx.doi.org/10.1016/S1534-5807(02)00222-8
   PubMed Web of Science ®Google Scholar
• Friesen WJ, Wyce A, Paushkin S, Abel L, Rappsilber J, Mann M, Dreyfuss G. A novel WD repeat protein component of the methylosome binds Sm proteins. J Biol Chem 2002; 277:8243-7; PMID:11756452; http://dx.doi.org/10.1074/jbc.M109984200
   PubMed Web of Science ®Google Scholar
• Guderian G, Peter C, Wiesner J, Sickmann A, Schulze-Osthoff K, Fischer U, Grimmler M. RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity. J Biol Chem 2010; 286:1976-86; PMID:21081503; http://dx.doi.org/10.1074/jbc.M110.148486
   PubMed Web of Science ®Google Scholar
• Lacroix M, El Messaoudi S, Rodier G, Le Cam A, Sardet C, Fabbrizio E. The histone-binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5. EMBO Rep 2008; 9:452-8; PMID:18404153; http://dx.doi.org/10.1038/embor.2008.45
   PubMed Web of Science ®Google Scholar
• Wilczek C, Chitta R, Woo E, Shabanowitz J, Chait BT, Hunt DF, Shechter D. Protein arginine methyltransferase Prmt5-Mep50 methylates histones H2A and H4 and the histone chaperone nucleoplasmin in Xenopus laevis eggs. J Biol Chem 2011; 286:42221-31; PMID:22009756; http://dx.doi.org/10.1074/jbc.M111.303677
   PubMed Web of Science ®Google Scholar
• Antonysamy S, Bonday Z, Campbell RM, Doyle B, Druzina Z, Gheyi T, Han B, Jungheim LN, Qian Y, Rauch C, et al. Crystal structure of the human PRMT5:MEP50 complex. Proc Natl Acad Sci U S A 2012; 109:17960-5; PMID:23071334; http://dx.doi.org/10.1073/pnas.1209814109
   PubMed Web of Science ®Google Scholar
• Ho MC, Wilczek C, Bonanno JB, Xing L, Seznec J, Matsui T, Carter LG, Onikubo T, Kumar PR, Chan MK, et al. Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity. PLoS One 2013; 8:e57008; PMID:23451136; http://dx.doi.org/10.1371/journal.pone.0057008
   PubMed Web of Science ®Google Scholar
• Zhao Q, Rank G, Tan YT, Li H, Moritz RL, Simpson RJ, Cerruti L, Curtis DJ, Patel DJ, Allis CD, et al. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing. Nat Struct Mol Biol 2009; 16:304-11; PMID:19234465; http://dx.doi.org/10.1038/nsmb.1568
   PubMed Web of Science ®Google Scholar
• Fabbrizio E, El Messaoudi S, Polanowska J, Paul C, Cook JR, Lee JH, Negre V, Rousset M, Pestka S, Le Cam A, et al. Negative regulation of transcription by the type II arginine methyltransferase PRMT5. EMBO Rep 2002; 3:641-5; PMID:12101096; http://dx.doi.org/10.1093/embo-reports/kvf136
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Vaites LP, Kim JK, Mellert H, Gurung B, Nakagawa H, Herlyn M, Hua X, Rustgi AK, McMahon SB, et al. Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell 2010; 18:329-40; PMID:20951943; http://dx.doi.org/10.1016/j.ccr.2010.08.012
   PubMed Web of Science ®Google Scholar
• Vashishtha M, Ng CW, Yildirim F, Gipson TA, Kratter IH, Bodai L, Song W, Lau A, Labadorf A, Vogel-Ciernia A, et al. Targeting H3K4 trimethylation in Huntington disease. Proc Natl Acad Sci U S A 2013; 110:E3027-36; PMID:23872847; http://dx.doi.org/10.1073/pnas.1311323110
   PubMed Web of Science ®Google Scholar
• Zuccato C, Marullo M, Conforti P, MacDonald ME, Tartari M, Cattaneo E. Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease. Brain Pathol 2008; 18:225-38; PMID:18093249; http://dx.doi.org/10.1111/j.1750-3639.2007.00111.x
   PubMed Web of Science ®Google Scholar
• Brahms H, Meheus L, de Brabandere V, Fischer U, Luhrmann R. Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA 2001; 7:1531-42; PMID:11720283; http://dx.doi.org/10.1017/S135583820101442X
   PubMed Web of Science ®Google Scholar
• Chang B, Chen Y, Zhao Y, Bruick RK. JMJD6 is a histone arginine demethylase. Science 2007; 318:444-7; PMID:17947579; http://dx.doi.org/10.1126/science.1145801
   PubMed Web of Science ®Google Scholar
• Hahn P, Bose J, Edler S, Lengeling A. Genomic structure and expression of Jmjd6 and evolutionary analysis in the context of related JmjC domain containing proteins. BMC Genomics 2008; 9:293; PMID:18564434; http://dx.doi.org/10.1186/1471-2164-9-293
   PubMed Web of Science ®Google Scholar
• Seong IS, Woda JM, Song JJ, Lloret A, Abeyrathne PD, Woo CJ, Gregory G, Lee JM, Wheeler VC, Walz T, et al. Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet 2009; 19:573-83; PMID:19933700; http://dx.doi.org/10.1093/hmg/ddp524
   PubMed Web of Science ®Google Scholar
• Krause CD, Yang ZH, Kim YS, Lee JH, Cook JR, Pestka S. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacol Ther 2007; 113:50-87; PMID:17005254; http://dx.doi.org/10.1016/j.pharmthera.2006.06.007
   PubMed Web of Science ®Google Scholar
• Rho J, Choi S, Seong YR, Cho WK, Kim SH, Im DS. Prmt5, which forms distinct homo-oligomers, is a member of the protein-arginine methyltransferase family. J Biol Chem 2001; 276:11393-401; PMID:11152681; http://dx.doi.org/10.1074/jbc.M008660200
   PubMed Web of Science ®Google Scholar
• Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 2012; 13:343-57; PMID:22473383; http://dx.doi.org/10.1038/nrg3173
   PubMed Web of Science ®Google Scholar
• Girardot M, Hirasawa R, Kacem S, Fritsch L, Pontis J, Kota SK, Filipponi D, Fabbrizio E, Sardet C, Lohmann F, et al. PRMT5-mediated histone H4 arginine-3 symmetrical dimethylation marks chromatin at G + C-rich regions of the mouse genome. Nucleic Acids Res 2013; 42:235-48; PMID:24097435; http://dx.doi.org/10.1093/nar/gkt884
   PubMed Web of Science ®Google Scholar
• Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 2012; 11:264-78; PMID:22748968; http://dx.doi.org/10.1016/j.stem.2012.04.027
   PubMed Web of Science ®Google Scholar
• Yu MC. The Role of Protein Arginine Methylation in mRNP Dynamics. Mol Biol Int 2011; 2011:163827; PMID:22091396; http://dx.doi.org/10.4061/2011/163827
   PubMedGoogle Scholar
• Bezzi M, Teo SX, Muller J, Mok WC, Sahu SK, Vardy LA, Bonday ZQ, Guccione E. Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery. Genes Dev 2013; 27:1903-16; PMID:24013503; http://dx.doi.org/10.1101/gad.219899.113
   PubMed Web of Science ®Google Scholar
• Webby CJ, Wolf A, Gromak N, Dreger M, Kramer H, Kessler B, Nielsen ML, Schmitz C, Butler DS, Yates JR, 3rd, et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science 2009; 325:90-3; PMID:19574390; http://dx.doi.org/10.1126/science.1175865
   PubMed Web of Science ®Google Scholar
• Wang F, He L, Huangyang P, Liang J, Si W, Yan R, Han X, Liu S, Gui B, Li W, et al. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation. PLoS Biol 2014; 12:e1001819; PMID:24667498; http://dx.doi.org/10.1371/journal.pbio.1001819
   PubMed Web of Science ®Google Scholar
• Cooper JK, Schilling G, Peters MF, Herring WJ, Sharp AH, Kaminsky Z, Masone J, Khan FA, Delanoy M, Borchelt DR, et al. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet 1998; 7:783-90; PMID:9536081; http://dx.doi.org/10.1093/hmg/7.5.783
   PubMed Web of Science ®Google Scholar
• Ratovitski T, Gucek M, Jiang H, Chighladze E, Waldron E, D'Ambola J, Hou Z, Liang Y, Poirier MA, Hirschhorn RR, et al. Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. J Biol Chem 2009; 284:10855-67; PMID:19204007; http://dx.doi.org/10.1074/jbc.M804813200
   PubMed Web of Science ®Google Scholar
• Cattaneo E, Conti L. Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J Neurosci Res 1998; 53:223-34; PMID:9671979; http://dx.doi.org/10.1002/(SICI)1097-4547(19980715)53:2%3c223::AID-JNR11%3e3.0.CO;2-7
   PubMed Web of Science ®Google Scholar
• Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 2000; 9:2799-809; PMID:11092756; http://dx.doi.org/10.1093/hmg/9.19.2799
   PubMed Web of Science ®Google Scholar
• Nucifora LG, Burke KA, Feng X, Arbez N, Zhu S, Miller J, Yang G, Ratovitski T, Delannoy M, Muchowski PJ, et al. Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein. J Biol Chem 2012; 287:16017-28; PMID:22433867; http://dx.doi.org/10.1074/jbc.M111.252577
   PubMed Web of Science ®Google Scholar
• Ko J, Ou S, Patterson PH. New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins. Brain Res Bull 2001; 56:319-29; PMID:11719267; http://dx.doi.org/10.1016/S0361-9230(01)00599-8
   PubMed Web of Science ®Google Scholar
• Watkin EE, Arbez N, Waldron-Roby E, O'Meally R, Ratovitski T, Cole RN, Ross CA. Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity. PLoS One 2014; 9:e88284; PMID:24505464; http://dx.doi.org/10.1371/journal.pone.0088284
   PubMed Web of Science ®Google Scholar